Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_assertion type Assertion NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_head.
- NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_assertion description "[These data suggest that the transcriptionally targeted hALA or oBLG driven expression of the HSVtk gene may be a feasible therapy for the treatment of human breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_provenance.
- NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_assertion evidence source_evidence_literature NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_provenance.
- NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_assertion SIO_000772 10505111 NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_provenance.
- NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_assertion wasDerivedFrom befree-20140225 NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_provenance.
- NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_assertion wasGeneratedBy ECO_0000203 NP505423.RADf_dHgQiJ_BAdraMczbOfSxkvvq4DQLZtxk_yX5CnGY130_provenance.